Bowel Screening Uptake Lower Among 50s as 100 Cancers Found Weekly

New data from NHS England indicates that participation in the national bowel cancer screening programme is notably lower among individuals in their 50s, even as the initiative continues to identify a significant number of malignancies each week. The latest annual figures, covering the period from April 2024 to March 2025, show that uptake among 54-year-olds stood at 56.2%. This rate trails the broader ambition for the programme, which health officials describe as a critical tool for early detection.

The screening programme, which relies on the faecal immunochemical test (FIT), is estimated to save over 2,000 lives annually. It currently detects around 100 cancers per week, often before any symptoms manifest. The FIT kit is dispatched to registered individuals aged 54 to 74 every two years, with the eligible age range being progressively expanded to include those aged 50 to 53.

Bowel cancer remains the fourth most common cancer in the UK. The screening initiative is designed to identify the disease at a stage when treatment is more likely to be successful. Despite this, the figures suggest a reluctance or delay among some eligible groups to complete and return the test.

The NHS bowel screening programme is one of the most effective ways to detect bowel cancer early, often before symptoms appear, and I would urge everyone eligible to complete their FIT kit when they receive it.

Steve Russell, NHS national director for screening and vaccination, emphasised the simplicity and privacy of the process.

Screening saves lives – it’s as simple as that. The FIT kit is quick, free, hygienic and can be done in the privacy of your own home.

The FIT kit requires a small stool sample, which is then posted to a laboratory for analysis. The test looks for minute traces of blood, a potential early indicator of bowel cancer or pre-cancerous polyps. Results are communicated within approximately two weeks, and those with abnormal findings are invited for further investigation, typically a colonoscopy.

The lower uptake among people in their 50s is a focal point for NHS England. The gradual reduction of the screening age from 60 to 50, which began in 2021, means a larger cohort of younger individuals is now receiving invitations. The 56.2% participation rate for 54-year-olds provides a benchmark for measuring engagement as the programme extends its reach.

Public health officials note that early-stage bowel cancer often presents no clear symptoms, making population-level screening a vital complement to symptomatic diagnosis. When symptoms such as persistent changes in bowel habit, blood in stool, or abdominal pain do appear, the disease may be more advanced. The screening programme aims to intercept the disease before this point.

The NHS has not attributed the participation gap to any single cause. Barriers to screening can include discomfort with the test, lack of awareness, or logistical challenges. The FIT kit’s design—completed at home without the need for a healthcare appointment—was intended to mitigate some of these obstacles.

According to NHS England, the programme’s detection rate of 100 cancers weekly underscores its effectiveness. The survival rate for bowel cancer diagnosed at the earliest stage is significantly higher than for late-stage diagnosis. The estimated 2,000 lives saved each year is a modelled figure based on the programme’s impact on mortality rates.

The expansion of the programme to those aged 50 to 53 is ongoing, with full rollout expected in the coming years. This will increase the number of eligible individuals and potentially the number of cancers detected. Health officials are monitoring uptake trends closely to inform targeted interventions aimed at boosting return rates.